5 doctors weigh in on the promise, limitations of a closely watched multicancer blood test
As a screening test from Grail moves closer to Food and Drug Administration approval, MedTech Dive asked cancer experts what encourages and concerns them most about Galleri.
We haven't written up this one. Healthcare Dive has the full story — the link below goes straight to it.